{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:20:23Z","timestamp":1783574423325,"version":"3.55.0"},"reference-count":102,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100002387","name":"NCI","doi-asserted-by":"publisher","award":["R01 CA282472"],"award-info":[{"award-number":["R01 CA282472"]}],"id":[{"id":"10.13039\/501100002387","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Virginia NCI"},{"name":"University of Virginia Department of Urology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Prostate cancer (PCa) represents a hormone-dependent malignancy where androgen receptor (AR) signaling plays a central role in disease initiation, progression, and therapeutic resistance. Recent advances have revealed that long noncoding RNAs (lncRNAs) constitute a critical regulatory layer in PCa, with implications for endocrine signaling pathways. lncRNAs orchestrate complex gene regulatory networks through diverse molecular mechanisms including chromatin remodeling, AR splice variant regulation, competitive endogenous RNA networks, translational control, and metabolic reprogramming. In castration-resistant PCa, dysregulated lncRNAs contribute to resistance against androgen deprivation therapy and next-generation AR antagonists such as enzalutamide. This review synthesizes current knowledge on lncRNA biology in PCa, emphasizing lncRNA relationships with AR signaling and endocrine resistance mechanisms. We discuss key lncRNAs that modulate AR activity, metabolic adaptation, and lineage plasticity. Additionally, we examine structure\u2013function relationships that enable rational therapeutic design, lncRNA roles in bone metastasis and neuroendocrine differentiation, and lncRNA clinical utility as biomarkers for disease progression and treatment stratification. Therapeutic strategies include antisense oligonucleotides, small-molecule inhibitors of lncRNA\u2013protein interaction disruptors, and combination approaches with DNA-damaging agents and AR inhibitors. Understanding lncRNA-mediated endocrine regulation provides insights into PCa biology and offers avenues for overcoming therapeutic resistance in advanced disease.<\/jats:p>","DOI":"10.1210\/endocr\/bqag076","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:42:46Z","timestamp":1782920566000},"source":"Crossref","is-referenced-by-count":0,"title":["Long noncoding RNAs mediate endocrine signaling and resistance in prostate cancer"],"prefix":"10.1210","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2284-8152","authenticated-orcid":false,"given":"Daniel","family":"Gioeli","sequence":"first","affiliation":[{"name":"Department of Urology, University of Virginia, and University of Virginia NCI-Designated Comprehensive Cancer Center , Charlottesville, VA 22908 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"1","key":"2026070901114504400_bqag076-B1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"26","key":"2026070901114504400_bqag076-B2","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1200\/JCO.23.00433","article-title":"Targeting the androgen signaling axis in prostate cancer","volume":"41","author":"Dai","year":"2023","journal-title":"J Clin Oncol"},{"key":"2026070901114504400_bqag076-B3","article-title":"Research progress of bone metastases: from disease recognition to clinical practice","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"issue":"3","key":"2026070901114504400_bqag076-B4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.3192","article-title":"The landscape of long noncoding RNAs in the human transcriptome","volume":"47","author":"Iyer","year":"2015","journal-title":"Nat Genet"},{"issue":"5","key":"2026070901114504400_bqag076-B5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.eururo.2019.07.040","article-title":"The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease management","volume":"76","author":"Ramnarine","year":"2019","journal-title":"Eur Urol"},{"issue":"1","key":"2026070901114504400_bqag076-B6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12943-019-1039-6","article-title":"Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth","volume":"18","author":"Ta","year":"2019","journal-title":"Mol Cancer"},{"issue":"1","key":"2026070901114504400_bqag076-B7","first-page":"151","article-title":"LncRNA HOTAIR: a master regulator of chromatin dynamics and cancer","volume":"1856","author":"Bhan","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"16","key":"2026070901114504400_bqag076-B8","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc9191","article-title":"Establishing RNA-RNA interactions remodels lncRNA structure and promotes PRC2 activity","volume":"7","author":"Balas","year":"2021","journal-title":"Sci Adv"},{"issue":"1","key":"2026070901114504400_bqag076-B9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.celrep.2015.08.069","article-title":"LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer","volume":"13","author":"Zhang","year":"2015","journal-title":"Cell Rep"},{"issue":"15-16","key":"2026070901114504400_bqag076-B10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1101\/gad.325050.119","article-title":"PRC2 is high maintenance","volume":"33","author":"Yu","year":"2019","journal-title":"Genes Dev"},{"issue":"4","key":"2026070901114504400_bqag076-B11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1261\/rna.037598.112","article-title":"Noncoding RNA and Polycomb recruitment","volume":"19","author":"Brockdorff","year":"2013","journal-title":"RNA"},{"issue":"16","key":"2026070901114504400_bqag076-B12","doi-asserted-by":"crossref","first-page":"14179","DOI":"10.18632\/oncotarget.3651","article-title":"Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR\/PRC2-androgen receptor (AR)-MMP9 signals and increased stem\/progenitor cell population","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"issue":"5992","key":"2026070901114504400_bqag076-B13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.1192002","article-title":"Long noncoding RNA as modular scaffold of histone modification complexes","volume":"329","author":"Tsai","year":"2010","journal-title":"Science"},{"key":"2026070901114504400_bqag076-B14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.canlet.2018.06.029","article-title":"HOTAIR is a REST-regulated lncRNA that promotes neuroendocrine differentiation in castration resistant prostate cancer","volume":"433","author":"Chang","year":"2018","journal-title":"Cancer Lett"},{"issue":"3","key":"2026070901114504400_bqag076-B15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cell.2018.06.014","article-title":"Risk SNP-mediated promoter-enhancer switching drives prostate cancer through lncRNA PCAT19","volume":"174","author":"Hua","year":"2018","journal-title":"Cell"},{"issue":"7464","key":"2026070901114504400_bqag076-B16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nature12451","article-title":"lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs","volume":"500","author":"Yang","year":"2013","journal-title":"Nature"},{"issue":"6","key":"2026070901114504400_bqag076-B17","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.18632\/oncotarget.1846","article-title":"The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancer","volume":"5","author":"Prensner","year":"2014","journal-title":"Oncotarget"},{"issue":"13","key":"2026070901114504400_bqag076-B18","doi-asserted-by":"crossref","first-page":"15481","DOI":"10.18632\/oncotarget.7139","article-title":"Regulation of androgen receptor splice variant AR3 by PCGEM1","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"2026070901114504400_bqag076-B19","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/emboj.2013.99","article-title":"Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer","volume":"32","author":"Takayama","year":"2013","journal-title":"EMBO J"},{"issue":"11","key":"2026070901114504400_bqag076-B20","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.3390\/ijms18112387","article-title":"The dark side of the epitranscriptome: chemical modifications in long non-coding RNAs","volume":"18","author":"Jacob","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2026070901114504400_bqag076-B21","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1002\/ctm2.426","article-title":"M6 A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization","volume":"11","author":"Lang","year":"2021","journal-title":"Clin Transl Med"},{"issue":"1","key":"2026070901114504400_bqag076-B22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-020-01293-4","article-title":"Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine","volume":"19","author":"Wen","year":"2020","journal-title":"Mol Cancer"},{"key":"2026070901114504400_bqag076-B23","doi-asserted-by":"crossref","DOI":"10.1177\/09636897221122997","article-title":"METTL3-mediated m6A modification of lncRNA MALAT1 facilitates prostate cancer growth by activation of PI3K\/AKT signaling","volume":"31","author":"Mao","year":"2022","journal-title":"Cell Transplant"},{"issue":"1","key":"2026070901114504400_bqag076-B24","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113149","article-title":"METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1\/c-Myc axis","volume":"416","author":"Liu","year":"2022","journal-title":"Exp Cell Res"},{"issue":"13","key":"2026070901114504400_bqag076-B25","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1158\/0008-5472.CAN-08-0594","article-title":"Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance","volume":"68","author":"Dehm","year":"2008","journal-title":"Cancer Res"},{"issue":"1","key":"2026070901114504400_bqag076-B26","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13668","article-title":"Truncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer","volume":"7","author":"Henzler","year":"2016","journal-title":"Nat Commun"},{"issue":"22","key":"2026070901114504400_bqag076-B27","doi-asserted-by":"crossref","first-page":"12216","DOI":"10.1073\/pnas.97.22.12216","article-title":"PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer","volume":"97","author":"Srikantan","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2026070901114504400_bqag076-B28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s42003-020-01120-y","article-title":"Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors","volume":"3","author":"Takayama","year":"2020","journal-title":"Commun Biol"},{"issue":"5","key":"2026070901114504400_bqag076-B29","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.eururo.2017.04.005","article-title":"Preclinical study using Malat1 small interfering RNA or androgen receptor splicing variant 7 degradation enhancer ASC-J9\u00ae to suppress enzalutamide-resistant prostate cancer progression","volume":"72","author":"Wang","year":"2017","journal-title":"Eur Urol"},{"issue":"10","key":"2026070901114504400_bqag076-B30","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41419-021-03966-4","article-title":"Targeting the Lnc-OPHN1-5\/androgen receptor\/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis"},{"issue":"1","key":"2026070901114504400_bqag076-B31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1158\/0008-5472.CAN-20-3845","article-title":"Loss of long noncoding RNA NXTAR in prostate cancer augments androgen receptor expression and enzalutamide resistance","volume":"82","author":"Ghildiyal","year":"2022","journal-title":"Cancer Res"},{"issue":"1","key":"2026070901114504400_bqag076-B32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12943-019-1037-8","article-title":"A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer","volume":"18","author":"Gu","year":"2019","journal-title":"Mol Cancer"},{"issue":"5","key":"2026070901114504400_bqag076-B33","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/1878-0261.12471","article-title":"The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program","volume":"13","author":"Parolia","year":"2019","journal-title":"Mol Oncol"},{"issue":"1","key":"2026070901114504400_bqag076-B34","doi-asserted-by":"crossref","first-page":"e1531","DOI":"10.1002\/ctm2.1531","article-title":"Androgen-repressed lncRNA LINC01126 drives castration-resistant prostate cancer by regulating the switch between O-GlcNAcylation and phosphorylation of androgen receptor","volume":"14","author":"Cai","year":"2024","journal-title":"Clin Transl Med"},{"issue":"8","key":"2026070901114504400_bqag076-B35","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41419-020-02856-5","article-title":"LINC00675 activates androgen receptor axis signaling pathway to promote castration-resistant prostate cancer progression","volume":"11","author":"Yao","year":"2020","journal-title":"Cell Death Dis"},{"issue":"15","key":"2026070901114504400_bqag076-B36","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk6989","article-title":"Androgen receptor\u2013regulated lncRNA PRCAT71 promotes AR signaling through the interaction with KHSRP in prostate cancer","volume":"11","author":"Yang","year":"2025","journal-title":"Sci Adv"},{"issue":"10","key":"2026070901114504400_bqag076-B37","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41419-021-04144-2","article-title":"LncRNA PCBP1-AS1-mediated AR\/AR-V7 deubiquitination enhances prostate cancer enzalutamide resistance","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis"},{"issue":"6","key":"2026070901114504400_bqag076-B38","first-page":"81","article-title":"The androgen regulated lncRNA NAALADL2-AS2 promotes tumor cell survival in prostate cancer","volume":"8","author":"Groen","year":"2022","journal-title":"Noncoding RNA"},{"issue":"3","key":"2026070901114504400_bqag076-B39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","article-title":"A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language?","volume":"146","author":"Salmena","year":"2011","journal-title":"Cell"},{"issue":"12","key":"2026070901114504400_bqag076-B40","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1158\/1535-7163.MCT-19-0095","article-title":"LncRNA CCAT1 promotes prostate cancer cell proliferation by interacting with DDX5 and MIR-28-5P","volume":"18","author":"You","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"2026070901114504400_bqag076-B41","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.636965","article-title":"Linc00963 promote cell proliferation and tumor growth in castration-resistant prostate cancer by modulating miR-655\/TRIM24 axis","volume":"11","author":"Bai","year":"2021","journal-title":"Front Oncol"},{"key":"2026070901114504400_bqag076-B42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.gene.2018.02.036","article-title":"Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer","volume":"654","author":"Chang","year":"2018","journal-title":"Gene"},{"issue":"3","key":"2026070901114504400_bqag076-B43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3892\/ijmm.2021.5015","article-title":"lncRNA SNHG11 facilitates prostate cancer progression through the upregulation of IGF-1R expression and by sponging miR-184","volume":"48","author":"Xie","year":"2021","journal-title":"Int J Mol Med"},{"issue":"55","key":"2026070901114504400_bqag076-B44","doi-asserted-by":"crossref","first-page":"94358","DOI":"10.18632\/oncotarget.21719","article-title":"LncRNA XIST acts as a tumor suppressor in prostate cancer through sponging miR-23a to modulate RKIP expression","volume":"8","author":"Du","year":"2017","journal-title":"Oncotarget"},{"key":"2026070901114504400_bqag076-B45","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2147\/CMAR.S231370","article-title":"LncRNA-SNHG16 silencing inhibits prostate carcinoma cell growth, downregulate GLUT1 expression and reduce glucose uptake","volume":"12","author":"Shao","year":"2020","journal-title":"Cancer Manag Res"},{"key":"2026070901114504400_bqag076-B46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129635","article-title":"Glycolysis related lncRNA SNHG3\/miR-139-5p\/PKM2 axis promotes castration-resistant prostate cancer (CRPC) development and enzalutamide resistance","volume":"260","author":"Yao","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"2026070901114504400_bqag076-B47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s11658-022-00313-z","article-title":"SNHG3 could promote prostate cancer progression through reducing methionine dependence of PCa cells","volume":"27","author":"Wang","year":"2022","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"2026070901114504400_bqag076-B48","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8693259","article-title":"LncRNA-MALAT1 regulates cancer glucose metabolism in prostate cancer via MYBL2\/mTOR axis","volume":"2022","author":"Mu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"2026070901114504400_bqag076-B49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-1-0716-3191-1_6","article-title":"Chemical probing of RNA structure in vivo using SHAPE-MaP and DMS-MaP","volume":"2666","author":"Saha","year":"2023","journal-title":"Methods Mol Biol"},{"issue":"7","key":"2026070901114504400_bqag076-B50","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1021\/acs.accounts.2c00782","article-title":"Single-molecule correlated chemical probing: a revolution in RNA structure analysis","volume":"56","author":"Mustoe","year":"2023","journal-title":"Acc Chem Res"},{"issue":"3","key":"2026070901114504400_bqag076-B51","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bbagen.2013.10.035","article-title":"Evolutionary conservation of long noncoding RNAs; sequence, structure, function","volume":"1840","author":"Johnsson","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"2026070901114504400_bqag076-B52","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/j.molcel.2023.06.024","article-title":"A lncRNA from the FTO locus acts as a suppressor of the m6A writer complex and p53 tumor suppression signaling","volume":"83","author":"Zhang","year":"2023","journal-title":"Mol Cell"},{"issue":"9","key":"2026070901114504400_bqag076-B53","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1261\/rna.080488.125","article-title":"Structural analysis of the lncRNA SChLAP1 reveals protein binding interfaces and a conformationally heterogenous retroviral insertion","volume":"31","author":"Falese","year":"2025","journal-title":"RNA"},{"issue":"19","key":"2026070901114504400_bqag076-B54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169350","article-title":"LncRNA SChLAP1 promotes cancer cell proliferation and invasion via its distinct structural domains and conserved regions","volume":"437","author":"Oh","year":"2025","journal-title":"J Mol Biol"},{"key":"2026070901114504400_bqag076-B55","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/bs.acr.2024.04.007","article-title":"Molecular landscape of prostate cancer bone metastasis","volume":"161","author":"Maji","year":"2024","journal-title":"Adv Cancer Res"},{"issue":"5","key":"2026070901114504400_bqag076-B56","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.3390\/ijms25052846","article-title":"Bridging the gap in understanding bone metastasis: a multifaceted perspective","volume":"25","author":"Elaasser","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026070901114504400_bqag076-B57","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116353","article-title":"RANKL biology","volume":"159","author":"Takegahara","year":"2022","journal-title":"Bone"},{"issue":"8","key":"2026070901114504400_bqag076-B58","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1002\/ctm2.493","article-title":"LncRNA nuclear-enriched abundant transcript 1 shuttled by prostate cancer cells-secreted exosomes initiates osteoblastic phenotypes in the bone metastatic microenvironment via miR-205-5p\/runt-related transcription factor 2\/splicing factor proline- and glutamine-rich\/polypyrimidine tract-binding protein 2 axis","volume":"11","author":"Mo","year":"2021","journal-title":"Clin Transl Med"},{"issue":"1","key":"2026070901114504400_bqag076-B59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1091\/mbc.e13-09-0558","article-title":"NEAT1 long noncoding RNA regulates transcription via protein sequestration within subnuclear bodies","volume":"25","author":"Hirose","year":"2014","journal-title":"Mol Biol Cell"},{"issue":"2","key":"2026070901114504400_bqag076-B60","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10616-023-00612-z","article-title":"NEAT1 promotes the progression of prostate cancer by targeting the miR-582-5p\/EZH2 regulatory axis","volume":"76","author":"Xu","year":"2024","journal-title":"Cytotechnology"},{"issue":"1","key":"2026070901114504400_bqag076-B61","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1080\/21655979.2021.2020393","article-title":"High expression of small nucleolar RNA host gene 3 predicts poor prognosis and promotes bone metastasis in prostate cancer by activating transforming growth factor-beta signaling","volume":"13","author":"Xi","year":"2022","journal-title":"Bioengineered"},{"issue":"2","key":"2026070901114504400_bqag076-B62","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3892\/ol.2022.13401","article-title":"Long non-coding RNA SNHG3 promotes prostate cancer progression by sponging microRNA-1827","volume":"24","author":"Hu","year":"2022","journal-title":"Oncol Lett"},{"issue":"1","key":"2026070901114504400_bqag076-B63","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41420-023-01585-w","article-title":"The long transcript of lncRNA TMPO-AS1 promotes bone metastases of prostate cancer by regulating the CSNK2A1\/DDX3X complex in Wnt\/\u03b2-catenin signaling","volume":"9","author":"Wang","year":"2023","journal-title":"Cell Death Discov"},{"issue":"5","key":"2026070901114504400_bqag076-B64","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11912-017-0593-6","article-title":"Emerging variants of castration-resistant prostate cancer","volume":"19","author":"Vlachostergios","year":"2017","journal-title":"Curr Oncol Rep"},{"issue":"24","key":"2026070901114504400_bqag076-B65","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1200\/JCO.2017.77.6880","article-title":"Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study","volume":"36","author":"Aggarwal","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"2026070901114504400_bqag076-B66","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.1038\/s41467-021-26901-9","article-title":"The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer","volume":"12","author":"Singh","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"2026070901114504400_bqag076-B67","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1038\/s41467-019-09784-9","article-title":"LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2\/STAT3 signaling","volume":"10","author":"Luo","year":"2019","journal-title":"Nat Commun"},{"key":"2026070901114504400_bqag076-B68","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101807","article-title":"MALAT1 promotes FOXA1 degradation by competitively binding to miR-216a-5p and enhancing neuroendocrine differentiation in prostate cancer","volume":"39","author":"Zeng","year":"2024","journal-title":"Transl Oncol"},{"issue":"28","key":"2026070901114504400_bqag076-B69","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1038\/onc.2017.50","article-title":"FOXA1 inhibits prostate cancer neuroendocrine differentiation","volume":"36","author":"Kim","year":"2017","journal-title":"Oncogene"},{"issue":"7","key":"2026070901114504400_bqag076-B70","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/1878-0261.12954","article-title":"The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms","volume":"15","author":"Mather","year":"2021","journal-title":"Mol Oncol"},{"key":"2026070901114504400_bqag076-B71","article-title":"Enzalutamide-induced upregulation of PCAT6 promotes prostate cancer neuroendocrine differentiation by regulating miR-326\/HNRNPA2B1 axis","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"2026070901114504400_bqag076-B72","article-title":"LINC00467 promotes prostate cancer progression via M2 macrophage polarization and the miR-494-3p\/STAT3 axis","volume":"11","author":"Jiang","year":"2021","journal-title":"Front Oncol"},{"issue":"9","key":"2026070901114504400_bqag076-B73","first-page":"3983","article-title":"REST-repressed lncRNA LINC01801 induces neuroendocrine differentiation in prostate cancer via transcriptional activation of autophagy","volume":"13","author":"Chang","year":"2023","journal-title":"Am J Cancer Res"},{"issue":"1","key":"2026070901114504400_bqag076-B74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.juro.2013.02.018","article-title":"PCA3 molecular urine test as a predictor of repeat prostate biopsy outcome in men with previous negative biopsies: a prospective multicenter clinical study","volume":"190","author":"Gittelman","year":"2013","journal-title":"J Urol"},{"issue":"5","key":"2026070901114504400_bqag076-B75","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrurol.2009.40","article-title":"The use of PCA3 in the diagnosis of prostate cancer","volume":"6","author":"Hessels","year":"2009","journal-title":"Nat Rev Urol"},{"issue":"3","key":"2026070901114504400_bqag076-B76","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.urology.2006.12.014","article-title":"PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy","volume":"69","author":"Marks","year":"2007","journal-title":"Urology"},{"issue":"3","key":"2026070901114504400_bqag076-B77","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/1078-0432.CCR-06-2679","article-title":"The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance","volume":"13","author":"van Gils","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"27","key":"2026070901114504400_bqag076-B78","doi-asserted-by":"crossref","first-page":"8403","DOI":"10.1073\/pnas.1507882112","article-title":"PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3","volume":"112","author":"Salameh","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2026070901114504400_bqag076-B79","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/jamaoncol.2024.0455","article-title":"Development and validation of an 18-gene urine test for high-grade prostate cancer","volume":"10","author":"Tosoian","year":"2024","journal-title":"JAMA Oncol"},{"issue":"2","key":"2026070901114504400_bqag076-B80","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrurol.2009.261","article-title":"Urine biomarkers in prostate cancer","volume":"7","author":"Ploussard","year":"2010","journal-title":"Nat Rev Urol"},{"key":"2026070901114504400_bqag076-B81","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ncrna.2025.10.005","article-title":"LncRNA expression in prostate cancer: from in silico analysis to urinary EV-based liquid biopsy for prognosis","volume":"16","author":"De Summa","year":"2026","journal-title":"Noncoding RNA Res"},{"issue":"22","key":"2026070901114504400_bqag076-B82","doi-asserted-by":"crossref","first-page":"11091","DOI":"10.18632\/oncotarget.2691","article-title":"Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"issue":"7 Suppl","key":"2026070901114504400_bqag076-B83","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/jco.2015.33.7_suppl.7","article-title":"Investigating the long noncoding RNA SChLAP1 as a prognostic tissue and urine biomarker in prostate cancer","volume":"33","author":"Feng","year":"2015","journal-title":"J Clin Oncol"},{"issue":"13","key":"2026070901114504400_bqag076-B84","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S1470-2045(14)71113-1","article-title":"RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1","volume":"15","author":"Prensner","year":"2014","journal-title":"Lancet Oncol"},{"issue":"8","key":"2026070901114504400_bqag076-B85","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neo.2016.07.001","article-title":"Identification and validation of PCAT14 as prognostic biomarker in prostate cancer","volume":"18","author":"Shukla","year":"2016","journal-title":"Neoplasia"},{"key":"2026070901114504400_bqag076-B86","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9494619","article-title":"lncRNA PCAT14 is a diagnostic marker for prostate cancer and is associated with immune cell infiltration","volume":"2021","author":"Yan","year":"2021","journal-title":"Dis Markers"},{"issue":"6","key":"2026070901114504400_bqag076-B87","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jmoldx.2014.06.009","article-title":"Long noncoding RNAs as putative biomarkers for prostate cancer detection","volume":"16","author":"Lee","year":"2014","journal-title":"J Mol Diagn"},{"key":"2026070901114504400_bqag076-B88","article-title":"Prognostic values of long noncoding RNA in bone metastasis of prostate cancer: a systematic review and meta-analysis","volume":"13","author":"Song","year":"2023","journal-title":"Front Oncol"},{"issue":"8","key":"2026070901114504400_bqag076-B89","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-22-0247","article-title":"Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases","volume":"30","author":"Sattari","year":"2023","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"2026070901114504400_bqag076-B90","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/ng.2771","article-title":"The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI\/SNF complex","volume":"45","author":"Prensner","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"2026070901114504400_bqag076-B91","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1186\/s12885-024-12926-y","article-title":"Single-cell sequencing analysis revealed that NEAT1 was a potential biomarker and therapeutic target of prostate cancer","volume":"24","author":"Li","year":"2024","journal-title":"BMC Cancer"},{"issue":"1","key":"2026070901114504400_bqag076-B92","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1038\/ncomms6383","article-title":"The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer","volume":"5","author":"Chakravarty","year":"2014","journal-title":"Nat Commun"},{"issue":"1","key":"2026070901114504400_bqag076-B93","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s41598-017-00966-3","article-title":"Therapeutic targeting using tumor specific peptides inhibits long non-coding RNA HOTAIR activity in ovarian and breast cancer","volume":"7","author":"\u00d6ze\u015f","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"2026070901114504400_bqag076-B94","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1021\/acsmedchemlett.6b00042","article-title":"Structure-guided discovery of selective antagonists for the chromodomain of polycomb repressive protein CBX7","volume":"7","author":"Ren","year":"2016","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"2026070901114504400_bqag076-B95","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12943-022-01540-w","article-title":"A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer","volume":"21","author":"Fletcher","year":"2022","journal-title":"Mol Cancer"},{"key":"2026070901114504400_bqag076-B96","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216247","article-title":"Non-coding RNAs in enzalutamide resistance of castration-resistant prostate cancer","volume":"566","author":"Gao","year":"2023","journal-title":"Cancer Lett"},{"issue":"1","key":"2026070901114504400_bqag076-B97","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-020-01267-6","article-title":"YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol Cancer"},{"issue":"6","key":"2026070901114504400_bqag076-B98","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgad203","article-title":"Identification of small-molecule inhibitors against the interaction of RNA-binding protein PSF and its target RNA for cancer treatment","volume":"2","author":"Takayama","year":"2023","journal-title":"PNAS Nexus"},{"issue":"6","key":"2026070901114504400_bqag076-B99","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad078","article-title":"Cancer cell\u2013extrinsic roles for the androgen receptor in prostate cancer","volume":"164","author":"Hahn","year":"2023","journal-title":"Endocrinology"},{"issue":"10","key":"2026070901114504400_bqag076-B100","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.3390\/ijms26104821","article-title":"A comprehensive review of long non-coding RNAs in the cancer-immunity cycle: mechanisms and therapeutic implications","volume":"26","author":"Perez-Medina","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2026070901114504400_bqag076-B101","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/genes16020229","article-title":"Unveiling racial disparities in localized prostate cancer: a systems-level exploration of the lncRNA landscape","volume":"16","author":"Morgan","year":"2025","journal-title":"Genes (Basel)"},{"issue":"5","key":"2026070901114504400_bqag076-B102","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3390\/genes16050527","article-title":"Competitive endogenous RNA network involving immune subgroups, infiltration, and lncRNAs in prostate cancer","volume":"16","author":"Niu","year":"2025","journal-title":"Genes (Basel)"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqag076\/68677387\/bqag076.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/167\/8\/bqag076\/68677387\/bqag076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/167\/8\/bqag076\/68677387\/bqag076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:12:04Z","timestamp":1783573924000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqag076\/8723459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":102,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,7,8]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqag076","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,7,2]]},"article-number":"bqag076"}}